← Open Payments lookup

OLUCHI CHILAKA: Open Payments

NPI 1336651520 · DENVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,412 in 284 payments from 16 companies in 2025. Trend: 2023 $4,260 · 2024 $6,102 · 2025 $6,412

Food & beverage: $6,183Education: $230
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.55$1,346
Neurocrine BioSciences, Inc.41$809
Alkermes, Inc.31$713
Otsuka America Pharmaceutical, Inc.34$677
Vanda Pharmaceuticals Inc.25$626
E.R. Squibb & Sons, L.L.C.23$562
ABBVIE INC.15$547
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$345
Supernus Pharmaceuticals, Inc.21$297
Lundbeck LLC9$155

Products named: UZEDY, INGREZZA, REXULTI, FANAPT, VRAYLAR, COBENFY, ARISTADA, CAPLYTA.

Industry payments across NJ — which companies pay providers there.